Weekly Article

AI found 29% more cancers. Then what? Is an AI biological age worth $499?

Three AI tools graded, a drug’s “younger” claim tested, and why AI drugs stall.

Your bone scan isn’t your fracture risk. The yearly vitamin D megadose that backfired

Three ways to protect bone graded, and a 94% stem-cell headline put in context.

AI can design peptides. Can it design longevity?

Generative AI, peptide design and digital twins are speeding discovery. Here is where the shortcut stops.

Your biological age fell. What changed?

One trial, three clocks, different answers. What to ask before paying for a younger number.

Your arm position is worth 6.5 mmHg

Wall squats beat running, salt beat a drug trial, and a Class 3 verdict on your wrist.

21 peptides graded. Only two got an A

The FDA's own scientists said no 🧬. Six of seven cleared a panel its own scientists opposed.

Your blood test measured the wrong thing 🧬

The £0 number that beats the £299 panel. One free calculation you can do tonight, one test worth £30 if you're in the right group, and one you only ever need once.

The muscle no supplement can sell you 🧬

Lifting graded A, protein graded B, and the £37 powder most people don't need.

Anti-ageing trial with 12 people 🧬

The anti-ageing molecule that wasn't 🧬

Taurine made mice live longer. And us? A 2023 headline, a 2025 reversal, and the one taurine claim that actually holds up.

The one stress supplement with real trials behind it — and the safety signal the gummies don't mention

Does ashwagandha actually work?

Are you really magnesium deficient? 🧬 Most magnesium is bought on a hunch

Half of us eat too little — far fewer are truly short. Plus: which form to buy, and why the spray barely gets in.

Who actually needs vitamin D? 🧬 Vitamin D keeps failing its big trials

VITAL and DO-HEALTH enrolled the wrong people. Plus: the one blood number — and why most of us shouldn't test it.

You probably need less salt, not more 🧬

The £45 electrolyte habit, audited.The powder industry sells you sodium — the hard-outcome trials point the other way. Plus: is "structured" water anything?

Your ice bath is taxing your gains 🧬

The cold plunge fixes today, taxes tomorrow- Most plungers time the cold exactly wrong — and the £300 ring can't read inflammation.

The Blueprint Audit: What 70 Pills a Day Actually Buys

70 pills, three that earn their place - The famous ageing-clock number isn't the win — the boring biomarker underneath it is. We audited the stack. Read on

Wegovy cut heart attacks by 20% 🧬

17,604 people, no diabetes, 20% fewer cardiac events — and the test that just told us these aren't ageing drugs after all.

The FDA just removed a 23-year warning 🧬

The pellet clinics already misreading the data 🔍5,246 men. 27,347 women. Two hormone files quietly rewritten — and the £400/month pellet clinics who are about to ride the rebound.

TRAVERSE didn’t say what your clinic claims 🧬

Three hormone routes graded across men and women. The £600-per-visit pellet model audited. Plus the FDA label change the WHI generation deserved twenty years ago.

Three sauna formats. One Grade A. 🧬Finland's 63% sauna mortality drop

One 20-year cohort. 2,315 men. The strongest mortality signal in the heat literature — plus the £549 blanket the data won't back.

£600 peptides: which ones actually work 🧬 And The one peptide your clinic won't mention

Plus: the at-home peptide kit problem nobody posts about. Grades inside article, plus the FDA-approved peptide nobody markets.

One best-selling gummy carried 347% of what the label claimed. What actually works is in the same aisle — at a sixth of the dose, for a fifth of the price.

The $4bn sleep aisle is a con - 0.3mg beats 10mg and nobody’s told you

Three brain supplements. One works

We graded Lion’s Mane, creatine, and phosphatidylserine. One is worth buying. The other two have better marketing than evidence. Plus: a £95/month nootropic subscription dismantled